https://env-syncromune-synct.kinsta.cloud/2022/02/12/syncromune-to-present-at-2022-bio-ceo-investor-conference/ 2022-12-13T13:25:47+00:00 https://env-syncromune-synct.kinsta.cloud/wp-content/uploads/2022/02/BIO-CEO-and-Investor-Conference.png https://env-syncromune-synct.kinsta.cloud/wp-content/uploads/2022/03/syncromune-logo-final-smart-white.png https://env-syncromune-synct.kinsta.cloud/wp-content/uploads/2019/07/syncromune-logo-10.20.21-x-small.png https://env-syncromune-synct.kinsta.cloud/2022/10/18/syncromune-inc-enters-into-an-exclusive-worldwide-license-agreement-with-eucure-biopharma-co-ltd-to-develop-and-commercialize-yh002-ox40-antibody-and-two-undisclosed-active-ingredients-as-comp/ 2023-02-07T19:51:26+00:00